Facility Planning
The topic is planned and the article has not been written yet. Nothing on this page is published technical guidance.
This article will examine the first decisions behind a new pharmaceutical plant: product portfolio and dosage forms, sterile or nonsterile scope, capacity and shift assumptions, site constraints, and the regulatory framework of the target markets. It will also explain how these inputs become a brief that design can build on.
If this question is live on your project, you do not need to wait for the article. Tell us about the facility and we can discuss it directly.
01Facility Planning
In preparationThis article will examine how QC and microbiology laboratories are zoned: separation of microbiology, sterility testing, and chemistry, dedicated air handling, sample and media flows, and decontamination before waste leaves the laboratory. It will also cover the utility and storage provisions that laboratory functions depend on.
02Facility Planning
In preparationThis article will examine recurring design problems in pharmaceutical facilities, such as crossing flows, AHUs serving conflicting zones, pressure cascades that exist only on drawings, undersized utilities, and monitoring or qualification needs left until handover. It will also look at how early reviews can catch them.
03Pharma Engineering
In preparationThis article will examine what each engineering phase is expected to decide and deliver, from zoning and flow strategy at concept stage, through system definitions, equipment lists, and layouts in basic engineering, to coordinated construction drawings and specifications in detailed engineering.
Next step
Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.
+20 101 171 1700